# Sientra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sientra

- Industry: Medical Devices & Equipment
- Headquarters: Santa Barbara, US
- Website: www.sientra.com
- Total disclosed funding: $109M
- Latest round: Series C (Mar 28, 2012)
- Investors on record: 5

## About

Based in California, US,  and founded in 2003 by its CEO Hani Zeini, Sientra, Inc. formerly known as Juliet Medical, Inc., operates as a medical aesthetics company that develops and sells medical aesthetics products for cosmetic and reconstructive surgery. In March 2012, Sientra, Inc. raised USD 65 million in series C funding led by Abingworth, with participation from Clarus Ventures and OrbiMed Advisors. The company is listed on the Nasdaq stock exchange with the ticker symbol SIEN.

Sientra, Inc. offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. 

The company has generated total revenue of 0.80 million in the fiscal year 2021.

Sientra, Inc. plans to use the series C funding to support the commercialization of the silicone breast implant portfolio as well as provide working capital and fund general operations.

## Funding rounds

- Series C, Mar 28, 2012, $65M — Abingworth, OrbiMed Advisors, Clarus Ventures
- Series B, Apr 18, 2007, $44M — OrbiMed Advisors, TIAA-CREF Life Insurance Company, Clarus Ventures, Goldman Sachs Asset Management

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- TIAA-CREF Life Insurance Company — Series B
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series B, Series C
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series B
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series C